[1] Chiappini E, Stival A, Galli L, et al. Pertussis re-emergence in the post-vaccination era[J]. BMC Infect Dis, 2013, 13:151-162.
[2] Matthias J, Pritchard PS, Martin SW, et al. Sustained transmission of pertussis in vaccinated, 1-5-year-old children in a preschool, Florida, USA[J]. Emerg Infect Dis, 2016, 22(2):242-246.
[3] Wood N, McIntyre P. Pertussis:review of epidemiology, diagnosis, management and prevention[J]. Paediatr Respir Rev, 2008, 9(3):201-212.
[4] Cornia PB, Hersh AL, Lipsky BA, et al. Does this coughing adolescent or adult patient have pertussis?[J]. JAMA, 2010, 304(8):890-896.
[5] Siriyakorn N, Leethong P, Tantawichien T, et al. Adult pertussis is unrecognized public health problem in Thailand[J]. BMC Infect Dis, 2016, 16:25.
[6] 王静敏, 杨永弘. 百日咳的研究现状[J]. 国外医学·流行病学传染病学分册, 2001, 28(2):67-70.
[7] Crowcroft NS, Pebody RG. Recent developments in pertussis[J]. Lancet, 2006, 367(9526):1926-1936.
[8] Cherry JD. Epidemic pertussis in 2012:the resurgence of a vaccine-preventable disease[J]. N Engl J Med, 2012, 367(9):785-787.
[9] Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence:waning immunity and pathogen adaptation-two sides of the same coin[J]. Epidemiol Infect, 2014, 142(4):685-694.
[10] Park S, Lee S, Seo K, et al. Epidemiological aspects of pertussis among adults and adolescents in a Korean outpatient setting:a multicenter, PCR-based study[J]. J Korean Med Sci, 2014, 29(9):1232-1239.
[11] 黄海涛, 高志刚. 百日咳再现及其应对策略的研究进展[J]. 医学综述, 2015, 21(9):1630-1632.
[12] Pimentel AM, Baptista PN, Ximenes RA, et al. Pertussis may be the cause of prolonged cough in adolescents and adults in the interepidemic period[J]. Braz J Infect Dis, 2015, 19(1):43-46.
[13] 米荣, 伏瑾, 王晓颖, 等. 迁延性咳嗽婴幼儿百日咳感染临床情况调查[J]. 中华医学杂志, 2013, 93(22):1721-1725.
[14] Stein-Zamir C, Shoob H, Abramson N, et al. The impact of additional pertussis vaccine doses on disease incidence in children and infants[J]. Vaccine, 2010, 29(2):207-211.
[15] Rohania P, Draked JM. The decline and resurgence of pertussis in the US[J]. Epidemics, 2011, 3(3-4):183-188.
[16] Mooi FR, van Loo IH, van Gent M, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence[J]. Emerg Infect Dis, 2009, 15(8):1206-1213.
[17] Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect[J]. Pediatr Infect Dis J,2003, 22(1):22-27.
[18] Wendelboe AM, Van Rie A, Salmaso S, et al. Duration of immunity against pertussis after natural infection or vaccination[J]. Pediatr Infect Dis J, 2005, 24(5 Suppl):S58-S61.
[19] Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies[J]. Clin Microbiol Rev, 2005, 18(2):326-382.
[20] 杨永弘, 马香. 小儿呼吸道感染的细菌病原[J]. 实用儿科临床杂志, 2011, 26(4):229-232.
[21] Wang K, Bettiol S, Thompson MJ, et al. Symptomatic treatment of the cough in whooping cough[]. Cochrane Database Syst Rev, 2014, (9):CD003257.
[22] Long SS, Edwards KM. Bordetella pertussis (Pertussis) and Other Species[M]//Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. 4th ed. Printed in China:Elsevir Saunders, 2012:858-866.
[23] Long SS, Lischner HW, Deforest A, et al. Serologic evidence of subclinical pertussis in immunized children[J]. Pediatr Infect Dis J, 1990, 9(10):700-705.
[24] Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families:antibody correlates of infection and symptomatology[J]. J Infect Dis, 1990, 161(3):480-486.
[25] Heininger U, Kleemann WJ, Cherry JD, et al. A controlled study of the relationship between Bordetella pertussis infection and sudden unexpected deaths in German infants[J]. Pediatrics, 2004, 114(1):e9-e15.
[26] Hartzell JD, Blaylock JM. Whooping cough in 2014 and beyond:an update and review[J]. Chest, 2014, 146(1):205-214.
[27] Kamiya H, Otsuka N, Ando Y, et al. Transmission of Bordetella holmesii during pertussis outbreak, Japan[J]. Emerg Infect Dis, 2012, 18(7):1166-1169.
[28] Mooi FR, Bruisten S, Linde I, et al. Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in The Netherlands[J]. FEMS Immunol Med Microbiol, 2012, 64(2):289-291.
[29] Tatti KM, Sparks KN, Boney KO, et al. Novel multitarget realtime PCR assay for rapid detection of Bordetella species in clinical specimens[J]. J Clin Microbiol, 2011, 49(12):4059-4066.
[30] Melvin JA, Scheller EV, Miller JF, et al. Bordetella pertussis pathogenesis:current and future challenges[J]. Nat Rev Microbiol, 2014, 12(4):274-288.
[31] Fedele G, Bianco M, Ausiello CM. The virulence factors of Bordetella pertussis:talented modulators of host immune response[J]. Arch Immunol Ther Exp (Warsz), 2013, 61(6):445-457.
[32] Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants[J]. Clin Infect Dis, 2008, 47(3):328-338.
[33] Hewlett EL, Bums DL, Cotter PA, et a1. Pertussis pathogenesiswhat we know and what we don't know[J]. J Infect Dis, 2014, 209(7):982-985.
[34] Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal[J]. Eur J Pediatr, 2000, 159(12):898-900.
[35] Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis:implications for immunization[J]. Expert Rev Vaccines, 2014, 13(9):1115-1123.
[36] Berger JT, Carcillo JA, Shanley TP, et a1. Critical pertussis illness in children:a muticenter prospective cohort study[J]. Pediatr Crit Care Med, 2013, 14(4):356-365.
[37] Surridge J, Segedin ER, Grant CC. Pertussis requiring intensive care[J]. Arch Dis Child, 2007, 92(11):970-975.
[38] Cherry JD, Tan T, Wirsing von König CH, et al. Clinical definitions of pertussis:summary of a global pertussis initiative roundtable meeting, February 2011[J]. Clin Infect Dis, 2012, 54(12):1756-1764.
[39] Guiso N, Wirsing von Koenig CH, Forsyth K, et al. The global pertussis initiative:report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010[J]. Vaccine, 2011, 29(6):1115-1121.
[40] Guiso N, Berbers G, Fry NK, et al. What to do an what not to do in serological diagnosis of pertussis:recommendations from EU reference laboratories[J]. Eur J Clin Microbiol Infect Dis, 2011, 30(3):307-312.
[41] Bock JM, Burtis CC, Poetker DM, et al. Serum immunoglobulin G analysis to establish a delayed diagnosis of chronic cough due to Bordetella pertussis[J]. Otolaryngol Head Neck Surg, 2012, 146(1):63-67.
[42] Heininger U. Pertussis:what the pediatric infectious disease specialist should know[J]. Pediatr Infect Dis J, 2012, 31(1):78-79.
[43] Altunaiji S, Kukuruzovic R, Curtis N, et al. Antibiotics for whooping cough (pertussis)[J]. Cochrane Database Syst Rev, 2007, (3):CD004404.
[44] Langley JM, Halperin SA, Boucher FD, et al. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis[J]. Pediatrics, 2004, 114(1):e96-e101.
[45] Bruss JB, Siber GR. Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model[J]. Clin Diagn Lab Immunol, 1999, 6(4):464-470.
[46] 胡云鸽, 刘泉波. 儿童百日咳247例临床特点及重症百日咳危险因素分析[J]. 中华儿科杂志, 2015, 53(9):684-689.
[47] Rocha G, Flôr-de-Lima F, Soares P, et al. Severe pertussis in newborns and young vulnerable infants[J]. Pediatr Infect Dis J, 2013, 32(10):1152-1154.
[48] McEniery JA, Delbridge RG, Reith DM. Infant pertussis deaths and the management of cardiovascular compromise[J]. J Paediatr Child Health, 2004, 40(4):230-232.
[49] Rowlands HE, Goldman AP, Harrington K, et al. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants[J]. Pediatrics, 2010, 126(4):e816-e827.
[50] 王静敏. 百日咳与百日咳疫苗[J]. 中华实用儿科临床杂志, 2013, 28(20):1530-1535.
[51] Xu Y, Tan Y, Asokanathan C, et al. Characterization of co-purified acellular pertussis vaccines[J]. Hum Vaccin Immunother, 2015, 11(2):421-427.
[52] 刁连东, 徐爱强, 杨永弘, 等. 百日咳免疫预防专家共识[J]. 中华流行病学杂志, 2011, 32(6):550-553.